Number of individual commercial milestones per target.

No definition available.

Name:	mer_CollaborationArrangementIndividualCommercialMilestonesTargetNumber
Namespace Prefix:	mer_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of individual development milestones per target.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementIndividualDevelopmentMilestonesTargetNumber
Namespace Prefix:	mer_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of individual regulatory milestones per target.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementIndividualRegulatoryMilestonesTargetNumber
Namespace Prefix:	mer_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of additional fees receivable when a target is designated and the commercial license to the target is granted under terms of the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsAdditionalPaymentToObtainDevelopmentAndCommercialLicense
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Maximum development milestone amount the company is entitled to receive under terms of the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsDevelopmentMilestones
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of the next potential development milestone the company will be eligible to receive.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsDevelopmentMilestonesPaymentReceivableNextMilestone
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Maximum aggregate milestone the Company is entitled to receive under terms of the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsMaximumAggregateMilestones
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Period of time before which prior written notice needs to be served for termination of the agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsPriorWrittenTerminationNoticeDuration
Namespace Prefix:	mer_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum regulatory milestone amount the company is entitled to receive under terms of the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsRegulatoryMilestones
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Maximum sales milestone amount the company is entitled to receive under terms of the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsSalesMilestones
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of targets designated as of balance sheet date.

+ References

No definition available.

+ Details

Name:	mer_CollaborationArrangementsTargetsDesignatedNumber
Namespace Prefix:	mer_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of exclusive targets entity provided right to develop under terms of agreement as of balance sheet date.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsExclusiveTargetsNumber
Namespace Prefix:	mer_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Portion of total potential arrangement consideration under the agreement related to expected fees for research services.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsExpectedFeesForResearchServices
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Estimated performance period in which revenue will be recognized, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsRevenueRecognitionPerformancePeriod
Namespace Prefix:	mer_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Estimated period in which revenue will be recognized beginning from time target is designated, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsRevenueRecognitionTerm
Namespace Prefix:	mer_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of total potential arrangement consideration under the agreement.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsTotalArrangementConsideration
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of upfront payment received during the period.

+ References

No definition available.

+ Details

Name:	mer_CollaborativeArrangementsUpfrontPayment
Namespace Prefix:	mer_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q1(c))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q2)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(c).Q3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

+ Details

Name:	us-gaap_DeferredRevenueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of consideration recognized during the period for the milestone or milestones.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 28
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=68058744&loc=SL6892177-166501

+ Details

Name:	us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represents the value established as the selling price of the significant unit of accounting used to allocate the consideration of the multiple-deliverable arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 25
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=68059916&loc=SL6750900-111635

+ Details

Name:	us-gaap_RevenueRecognitionMultipleDeliverableArrangementsDeterminationOfSellingPriceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=mer_CollaborationAndCommercialLicenseAgreementMerckKgaaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=mer_FirstAndSecondTargetsCombinedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=mer_LicenseAndRelatedResearchAndDevelopmentServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=mer_RightsToFutureTechnologicalImprovementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=mer_JointResearchCommitteeServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Collaboration agreements - Merck KGaA Agreement (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		31 Months Ended
	Jun. 30, 2014 USD ($) item	Sep. 30, 2017 USD ($) item	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) item	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Collaboration agreements
Collaboration revenue		$ 6,267	$ 3,262	$ 14,284	$ 13,175
Accounts receivable		731		731		$ 1,051
Deferred revenue, current		16,476		16,476		22,731
Merck KGaA
Collaboration agreements
Upfront payment received	$ 12,000
Number of targets \| item	6
Amount of additional fees receivable when target is designated and commercial license to target is granted	$ 0
Aggregate milestones	780,000
Development milestones	84,000
Regulatory milestones	264,000
Sales milestones	$ 432,000
Number of individual development milestones per target \| item	6
Number of individual regulatory milestones per target \| item	5
Number of individual commercial milestones per target \| item	3
Milestone revenue received and recognized		500				2,000
Next potential development milestone payment eligible to receive		$ 500		$ 500
Number of targets designated \| item	6	6		6
Prior written notice for termination period	60 days
Total arrangement consideration	$ 23,025	$ 19,875		$ 19,875
Expected fees for research services	11,025	7,875		7,875
Collaboration revenue		499	$ 777	2,107	$ 2,656
Accounts receivable		51		51		509
Deferred revenue		7,335		7,335		8,236
Deferred revenue, current		5,213		$ 5,213		$ 6,195
First and second targets combined \| Merck KGaA
Collaboration agreements
Selling price allocation		6,428
License and corresponding research and development services \| Merck KGaA
Collaboration agreements
Selling price allocation	$ 3,723	3,214
Estimated period in which revenue will be recognize	36 months
Future technological improvements \| Merck KGaA
Collaboration agreements
Selling price allocation	$ 437	376
Estimated performance period in which revenue will be recognized	10 years
Joint research committee services \| Merck KGaA
Collaboration agreements
Selling price allocation	$ 248	$ 214
Estimated performance period in which revenue will be recognized	6 years